Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hims & Hers Health, Inc.HIMS · Entity 1878 | Chief Operating Officer | May 12, 2025 | May 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hims & Hers Health, Inc.
Report date May 12, 2025 · Filed May 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 805,083 |
Ending reported balance
After 2025-05-12 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2025-05-12 · Exercise / conversion · Acquired 33,333 · Balance 838,416 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. Row 2 · 2025-05-12 · Sale · Disposed 13,786 · Balance 824,630 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.405 - $55.395. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Row 3 · 2025-05-12 · Sale · Disposed 6,801 · Balance 817,829 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F3: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.405 - $56.315. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Row 4 · 2025-05-12 · Sale · Disposed 7,556 · Balance 810,273 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F4: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.425 - $57.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Row 5 · 2025-05-12 · Sale · Disposed 5,190 · Balance 805,083 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F5: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.45 - $58.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.43 · Expires 2030-05-13 | Direct | 693,795 |
Reported balance
After 2025-05-12 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-05-12 · Exercise / conversion · Disposed 33,333 · Balance 693,795 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F6: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.
F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.405 - $55.395. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.405 - $56.315. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.425 - $57.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F5: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.45 - $58.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F6: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 20, 2021 Filed Jan 22, 2021 21:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantStock Option (right to buy) · Derivative | 779,073 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0000899243-21-003122 · doc4.xml · derivative · entry 6 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 779,073 Underlying: Class A Common Stock · 779,073 shares Expires 2030-05-12 F7 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 1,719,884 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning February 12, 2020. The Stock Option is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable Stock Option Agreement). Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 21:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantStock Option (right to buy) · Derivative | 113,245 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0000899243-21-003122 · doc4.xml · derivative · entry 5 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,245 Underlying: Class A Common Stock · 113,245 shares Expires 2029-11-05 F6 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 250,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $0.79, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning October 1, 2019. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 21:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantStock Option (right to buy) · Derivative | 925,664 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0000899243-21-003122 · doc4.xml · derivative · entry 4 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 925,664 Underlying: Class A Common Stock · 925,664 shares Expires 2028-03-28 F5 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 2,043,499 shares of Class A Common Stock of Hims, Inc., with an exercise price of $0.18, in connection with the Merger. 1/4 of the shares subject to the Stock Option vest on the 12 month anniversary of the vesting commencement date and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the 12 month anniversary of the vesting commencement date, beginning February 6, 2018. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 21:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantStock Option (right to buy) · Derivative | 161,059 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0000899243-21-003122 · doc4.xml · derivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,059 Underlying: Class A Common Stock · 161,059 shares Expires 2028-03-28 F4 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 355,555 shares of Class A Common Stock of Hims, Inc., with an exercise price of $0.18, in connection with the Merger. 1/4 of the shares subject to the Stock Option vest on the 12 month anniversary of the vesting commencement date and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the 12 month anniversary of the vesting commencement date, beginning February 6, 2018. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 21:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantWarrant (right to buy) · Derivative | 556 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000899243-21-003122 · doc4.xml · derivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 556 Underlying: Class A Common Stock · 556 shares Expires 2026-01-20 F3 · derivative.exercise_date: In connection with the Merger, the Reporting Person received warrants exercisable for shares of New Hims Class A Common Stock in partial exchange for shares of Class A Common Stock of Hims, Inc. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 21:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantClass A Common Stock | 99,458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-003122 · doc4.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,458 F1 · price: In connection with the merger described in that certain Agreement and Plan of Merger, dated as of September 30, 2020 (the "Merger"), by and among Oaktree Acquisition Corp., now known as Hims & Hers Health, Inc. ("New Hims"), RX Merger Sub Inc., and Hims, Inc., the Reporting Person received (i) 90,596 shares of Class A Common Stock of New Hims and (ii) 8,862 shares of restricted New Hims Class A Common Stock (the "Earn Out Shares") in exchange for 200,000 shares of Class A Common Stock of Hims, Inc. The Earn Out Shares vest in equal thirds if the trading price of New Hims Class A Common Stock is greater than or equal to $15, $17.50 and $20 for any 10 trading days within any 20-trading day period (the "Earn Out Conditions"). If the Earn Out Conditions are not met during the five years following closing (the "Earn Out Period"), then the unvested Earn Out Shares will be automatically forfeited. F2 · price: (Continued from footnote 1)On the effective date of the Merger, the closing price of New Hims Class A Common Stock was $16.38 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.